Arikayce liposomal

amikacin sulfate · Insmed Netherlands B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arikayce liposomal, covering 2025-10-14 to 2026-08-05. Get the full timeline:

Most recent: EMA Authorised: Arikayce liposomal (amikacin sulfate) — Insmed Netherlands B.V.